3D brain view may help treat Alzheimer's, Parkinson's

Image
IANS New York
Last Updated : Jun 29 2014 | 1:35 PM IST

In a breakthrough that may help in developing drugs for Alzheimer's and other neurological disorders, researchers have developed a 3D view of an important receptor in the brain.

This receptor allows us to learn and remember, and its dysfunction can result in a wide range of neurological diseases including Alzheimer's, Parkinson's, schizophrenia and depression.

The unprecedented view gives scientists new insight into how the receptor - called the NMDA receptor - is structured.

And importantly, the new detailed view gives vital clues for developing drugs to combat neurological diseases and conditions.

"This is the most exciting moment of my career," said Eric Gouaux, a senior scientist with Oregon Health and Science University in the US.

"The NMDA receptor is one of the most essential, and still sometimes mysterious, receptors in our brain. Now, with this work, we can see it in fascinating detail," he said.

Receptors facilitate chemical and electrical signals between neurons in the brain allowing them to communicate with each other.

The NMDA (N-methyl-D-aspartate) receptor facilitates neuron communication that is the foundation of memory, learning and thought.

Malfunction of the NMDA receptor occurs when it is increasingly or decreasingly active.

The NMDA receptor makeup includes receptor "subunits" - all of which have distinct properties and act in distinct ways in the brain, sometimes causing neurological problems.

Prior to Gouaux's study, scientists had only a limited view of how those subtypes were arranged in the NMDA receptor complex and how they interacted to carry out specific functions within the brain and the central nervous system.

Gouaux's team of scientists created a 3D model of the NMDA receptor through a process called X-ray crystallography.

"This new detailed view will be invaluable as we try to develop drugs that might work on specific subunits and therefore help fight or cure some of these neurological diseases and conditions," Gouaux said.

"Seeing the structure in more detail can unlock some of its secrets and may help a lot of people," he added.

The findings were published online in the journal Nature.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 29 2014 | 1:24 PM IST

Next Story